Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists

被引：14

作者：

Pettersson, Martin ^{[1
]}

Campbell, Brian M. ^{[1
]}

Dounay, Amy B. ^{[1
]}

Gray, David L. ^{[1
]}

Xie, Longfei ^{[1
]}

O'Donnell, Christopher J. ^{[1
]}

Stratman, Nancy C. ^{[1
]}

Zoski, Kim ^{[1
]}

Drummond, Elena ^{[1
]}

Bora, Gary ^{[1
]}

Probert, Al ^{[1
]}

Whisman, Tammy ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Groton, CT 06340 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 02期

关键词：

Norepinephrine reuptake inhibitor; 5-HT1A agonist; NRI; NET; DAT; SERT; ADHD; Depression; EFFICACY; REBOXETINE;

D O I：

10.1016/j.bmcl.2010.11.066

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Compounds with combined norepinephrine reuptake inhibitor (NRI) and serotonin 1A (5-HT1A) partial agonist pharmacology may offer a new therapeutic approach for treating symptoms of neuropsychiatric disorders including ADHD, depression, and anxiety. Herein we describe the design and optimization of novel chemical matter that exhibits favorable dual NRI and 5-HT1A partial agonist activity. Lead compounds in this series were found to be devoid of activity at the dopamine transporter and were shown to be brain penetrant with high receptor occupancy. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：865 / 868

页数：4

共 50 条

[41] Pharmacological MRI to investigate the functional selectivity of 5-HT1A receptor biased agonists
Vidal, Benjamin
Bolbos, Radu
Redoute, Jerome
Langlois, Jean-Baptiste
Costes, Nicolas
Newman-Tancredi, Adrian
Zimmer, Luc
NEUROPHARMACOLOGY, 2020, 172
[42] Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors
Paudel, Suresh
Cao, Yongkai
Guo, Shuohan
An, Byeongkwan
Kim, Kyeong-Man
Cheon, Seung Hoon
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (19) : 6418 - 6426
[43] 5-HT1A and 5-HT1B receptor agonists and aggression:: A pharmacological challenge of the serotonin deficiency hypothesis
de Boer, SF
Koolhaas, JM
EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 526 (1-3) : 125 - 139
[44] BEHAVIORAL PHARMACOLOGICAL AND ELECTROENCEPHALOGRAPHIC EFFECTS OF THE 5-HT1A PARTIAL AGONIST IPSAPIRONE
YAMAMOTO, T
SHIBATA, S
TESHIMA, K
INOUE, Y
USHIO, M
TOMINAGA, K
OHNO, M
WATANABE, S
UEKI, S
FOLIA PHARMACOLOGICA JAPONICA, 1991, 98 (01) : 41 - 52
[45] Synthesis and Dual 5-HT1A/SSRI Activities of Some Novel Arylpiperazine Derivatives of Duloxetine
Chen, Shao-Rui
Li, Ai-Jun
Chen, Ming-Ming
ASIAN JOURNAL OF CHEMISTRY, 2012, 24 (04) : 1680 - 1684
[46] Design, synthesis, and preliminary evaluation of new pyrrolidine derivatives as neuraminidase inhibitors
Zhang, Jie
Xu, Wenfang
Liu, Ailin
Du, Guanhua
MEDICINAL CHEMISTRY, 2008, 4 (03) : 206 - 209
[47] N-Desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity
Jensen, Niels H.
Rodriguiz, Ramona M.
Caron, Marc G.
Wetsel, William C.
Rothman, Richard B.
Roth, Bryan L.
NEUROPSYCHOPHARMACOLOGY, 2008, 33 (10) : 2303 - 2312
[48] N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT1A Agonist, as a Putative Mediator of Quetiapine's Antidepressant Activity
Niels H Jensen
Ramona M Rodriguiz
Marc G Caron
William C Wetsel
Richard B Rothman
Bryan L Roth
Neuropsychopharmacology, 2008, 33 : 2303 - 2312
[49] FURTHER EVIDENCE FOR THE IMPORTANCE OF 5-HT1A AUTORECEPTORS IN THE ACTION OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS
HJORTH, S
AUERBACH, SB
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 260 (2-3) : 251 - 255
[50] Full and partial 5-HT1A receptor agonists disrupt learning and performance in rats
Winsauer, PJ
Rodriguez, FH
Cha, AE
Moerschbaecher, JM
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (01): : 335 - 347

← 1 2 3 4 5 →